Granules India is currently trading at Rs. 195.00, up by 1.30 points or 0.67% from its previous closing of Rs. 193.70 on the BSE.
The scrip opened at Rs. 193.05 and has touched a high and low of Rs. 195.90 and Rs. 191.35 respectively. So far 8970 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 234.50 on 11-Sep-2012 and a 52 week low of Rs. 55.00 on 12-Dec-2011.
Last one week high and low of the scrip stood at Rs. 211.40 and Rs. 190.35 respectively. The current market cap of the company is Rs. 389.38 crore.
The promoters holding in the company stood at 44.28% while Institutions and Non-Institutions held 1.75% and 53.52% respectively.
Granules India, a fast growing pharmaceutical manufacturing Company, has been recognized as India’s Most Admired Company in Exports & India’s Most Admired Company in Bulk Drugs.
The company has been recognized at the 5th Annual Pharmaceutical Business Leadership Awards organized by Pharmaleaders in association with BSE, Pharmexcil and IBEF.
Granules is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: